JANUARY 25, 2017
A presentation at the Moscow State University by CSO Dr. Misha Shchepinov regarding the mechanism of action of Retrotope's RT001, and its effectiveness in a variety of disease models.
October 12, 2015
A presentation at the University of Pennsylvania by Dr. Harry J. Saal, regarding how Retrotope's RT001 addresses the orphan disease Friedreich's ataxia.
August 22, 2015
Interview of CEO Dr. Bob Molinari by Kyle Bryant (FARA) about the RT001 First in Human clinical trial in Friedreich's ataxia.
JUNE 17, 2015
Presentation by Dr. Charles Cantor at ideacity 2015, Toronto, Canada.
JUNE 6, 2015
Interview w Dr. Bob Molinari, CEO and Dr. Harry J. Saal, Chairman